Koconis John 4
4 · Timber Pharmaceuticals, Inc. · Filed Sep 16, 2021
Insider Transaction Report
Form 4
Koconis John
DirectorChief Executive Officer
Transactions
- Award
Stock Option (right to buy)
2021-09-14+890,000→ 890,000 totalExercise: $0.89Exp: 2031-09-13→ Common Stock, par value $0.001 per share (890,000 underlying)
Footnotes (1)
- [F1]The shares underlying the options will vest in equal 36 monthly installments beginning on October 14, 2021, as long as the reporting person remains continuously employed through each vesting date.